|
|
||||||||
Original Research Communication |
From the Departments of Medical Genetics, Clinical Chemistry, and Epidemiology and Health Surveillance, Ullevål University Hospital, Oslo, and the Institute of Medical Genetics and the Institute of General Practice and Community Medicine, Department of Epidemiological Research, University of Oslo.
Background: Elevated concentrations of plasma total homocysteine (tHcy) and serum total cholesterol are risk factors for ischemic heart disease (IHD). Previous studies showed that the consumption of very high doses of unfiltered coffee increases tHcy and total cholesterol.
Objective: A prospective intervention study was performed to assess the effects of coffee consumption on the concentrations of tHcy and total cholesterol by using doses and brewing methods common in southeastern Norway.
Design: The study was an unblinded, controlled trial with 191 healthy, nonsmoking, coffee-drinking volunteers aged 2469 y randomly assigned to 3 groups who were asked to consume for 6 consecutive weeks no coffee, 13 cups (
175525 mL)/d, or
4 cups(
700 mL)/d prepared in the manner to which they were accustomed. Blood samples were drawn when the subjects were randomly assigned and at 3 and 6 wk of the trial. Dietary data were collected by questionnaire.
Results: Ninety-seven percent of the participants reported being regular consumers of caffeinated filtered coffee. Abstention from coffee for 6 wk was associated with a decrease in the tHcy concentration of 1.08 µmol/L and a decrease in the total cholesterol concentration of 0.28 mmol/L in participants who had been drinking on average 4 cups of filtered coffee daily for the past year. Adjustments for several possible confounders did not alter the results.
Conclusion: Abstention from filtered coffee in doses that are commonly consumed was associated with lower concentrations of tHcy and total cholesterol.
Key Words: Filtered coffee homocysteine cholesterol folate ischemic heart disease
This article has been cited by other articles:
![]() |
A. Ulvik, S. E. Vollset, G. Hoff, and P. M. Ueland Coffee Consumption and Circulating B-Vitamins in Healthy Middle-Aged Men and Women Clin. Chem., September 1, 2008; 54(9): 1489 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Greenberg, C. N Boozer, and A. Geliebter Coffee, diabetes, and weight control. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 682 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nurk, G. S Tell, S. E Vollset, O. Nygard, H. Refsum, R. M Nilsen, and P. M Ueland Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, May 1, 2004; 79(5): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chrysohoou, D. B Panagiotakos, C. Pitsavos, A. Zeimbekis, A. Zampelas, L. Papademetriou, C. Masoura, and C. Stefanadis The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study Vascular Medicine, May 1, 2004; 9(2): 117 - 123. [Abstract] [PDF] |
||||
![]() |
J. E. James Critical Review of Dietary Caffeine and Blood Pressure: A Relationship That Should Be Taken More Seriously Psychosom Med, January 1, 2004; 66(1): 63 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Christensen, A. Mosdol, and D. S Thelle Reply to TMS Wolever Am. J. Clinical Nutrition, May 1, 2002; 75(5): 949 - 950. [Full Text] |
||||
![]() |
T. M. Wolever Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol Am. J. Clinical Nutrition, May 1, 2002; 75 (5): 948 - 949. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |